Back to search

Article

eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancer

2025-10-03

Abstract excerpt

<h4>ABSTRACT</h4> With FDA approval of targeted therapies in patients with germline BRCA1/2-related advanced cancers there is a need to evaluate efficient and effective delivery models for germline cancer genetic testing. We sought to evaluate the effectiveness of replacing traditional pretest and posttest counseling with a genetic counselor (GC) with a digital intervention in patients with metastatic cancers. eR...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c23fe07f-a196-577a-a887-eee47ed8e4cd
DOI
10.1101/2025.10.01.25337108
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancerDOI 10.1101/2025.10.01.25337108
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocolSemantic proximity
An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial.Semantic proximity
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialSemantic proximity
Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service deliverySemantic proximity
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary CareSemantic proximity
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.Semantic proximity
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.Semantic proximity
Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing.Semantic proximity
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselorsSemantic proximity
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.Semantic proximity
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline TestingSemantic proximity
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.Semantic proximity
Select a neighboring publication to make it the new centre.